WBR0278: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 26: Line 26:
Nephroblastoma may be present in isolation or may be caused by genetic deletions that involve the ''[[WT1]]'' [[tumor suppressor gene]] in [[chromosome]] 11 that result in [[WAGR syndrome]] (Wilms tumor, [[aniridia]], [[genitourinary abnormalities]], and [[retardation]]). ''WT1'' gene encodes a transcription factor that normally functions in the differentiation of renal and genitourinary tissue. Nephroblastoma has also been associated with [[Beckwith-Weidemann syndrome]] ([[hemihypertrophy]] of organs).  
Nephroblastoma may be present in isolation or may be caused by genetic deletions that involve the ''[[WT1]]'' [[tumor suppressor gene]] in [[chromosome]] 11 that result in [[WAGR syndrome]] (Wilms tumor, [[aniridia]], [[genitourinary abnormalities]], and [[retardation]]). ''WT1'' gene encodes a transcription factor that normally functions in the differentiation of renal and genitourinary tissue. Nephroblastoma has also been associated with [[Beckwith-Weidemann syndrome]] ([[hemihypertrophy]] of organs).  


Generally, children with a palpable abdominal mass should first undergo an [[abdominal ultrasound]]; suspicious findings warrant an [[abdominal CT scan]]. The classical finding of nephroblastoma on abdominal CT scan include a solid renal mass with normal renal parenchyma towards its rim ([[claw sign]]), as observed in this patient. In contrast to neuroblastoma, calcifications are rare in nephroblastoma. Nephroblastoma is generally managed surgically followed by [[chemotherapy]]. [[Radiotherapy]] is conserved for advanced cases with metastasis. Upon resection, microscopic analysis of the tumor typically reveals immature blasts with primitive glomeruli, fibrous cells, and tubules.
Generally, children with a palpable abdominal mass should first undergo an [[abdominal ultrasound]]; suspicious findings warrant an [[abdominal CT scan]]. The classical finding of nephroblastoma on abdominal CT scan include a solid renal mass with normal renal parenchyma towards its rim ([[claw sign]]), as observed in this patient. In contrast to neuroblastoma, calcifications are rare in nephroblastoma. Nephroblastoma is generally managed surgically followed by [[chemotherapy]]. [[Radiotherapy]] is reserved for advanced cases with metastasis. Upon resection, microscopic analysis of the tumor typically reveals immature blasts with primitive glomeruli, fibrous cells, and tubules.
|AnswerA=Deletion on chromosome 11
|AnswerA=Deletion on chromosome 11
|AnswerAExp=[[Nephroblastoma]] ([[Wilms tumor]]) is often caused by deletion of ''WT1'' tumor suppressor gene on chromosome 11. ''WT1'' is eponymously named Wilm's Tumor 1 gene.
|AnswerAExp=[[Nephroblastoma]] (Wilms or [[Wilms' tumor]]) is often caused by ''WT1'' tumor suppressor gene deletion on chromosome 11. ''WT1'' is eponymously named Wilms Tumor 1 gene.
|AnswerB=Mutation of ''TSC2''
|AnswerB=Mutation of ''TSC2''
|AnswerBExp=''[[TSC2]]'' is a tumor suppressor gene in the [[MTOR]] pathway. Mutations in ''TSC2'' cause [[tuberous sclerosis]], which is characterized by the growth of benign tumors in the brain, skin, kidneys, and other organs.
|AnswerBExp=''[[TSC2]]'' is a tumor suppressor gene in the [[MTOR]] pathway. Mutations in ''TSC2'' cause [[tuberous sclerosis]], which is characterized by the growth of benign tumors in the brain, skin, kidneys, and other organs.
|AnswerC=Mutation of ''VHL''
|AnswerC=Mutation of ''VHL''
|AnswerCExp=The [[Von-Hippau-Lindau]] (''[[VHL]]'') gene encodes a ubiquitin-ligase responsible for increasing the degradation of Hypoxia-Inducible Factor (HIF), a transcription factor involved in a variety of gene products, such as Vascular Endothelial Growth Factor ([[VEGF]]). When the ''VHL'' gene is inactivated, HIF activity increases uncontrollably and initiates tumor formation in kidney cells. Germline mutations in the ''VHL'' tumor suppressor gene are associated with Von-Hippau-Lindau, a cancer-predisposing syndrome.
|AnswerCExp=The [[Von-Hippau-Lindau]] (''[[VHL]]'') gene encodes a ubiquitin-ligase responsible for increasing the degradation of Hypoxia-Inducible Factor (HIF), a transcription factor involved in a variety of gene products, such as Vascular Endothelial Growth Factor ([[VEGF]]). When the ''VHL'' gene is inactivated, HIF activity increases uncontrollably and initiates tumor formation in kidney cells. Germline mutations in the ''VHL'' tumor suppressor gene are associated with Von-Hippau-Lindau, a cancer-predisposing syndrome.
|AnswerD=Trinucleotide repeats  
|AnswerD=Trinucleotide repeats
|AnswerDExp=Trinucleotide repeats is not associated with nephroblastoma. Huntington's disease (CAG repeats), myotonic dystrophy (CTG repeats), Fragile X syndrome (GAA repeats), and Friedreich ataxia (GAA repeats) are caused by trinucleotide repeats.
|AnswerDExp=Trinucleotide repeats is not associated with nephroblastoma. Huntington's disease (CAG repeats), myotonic dystrophy (CTG repeats), Fragile X syndrome (GAA repeats), and Friedreich ataxia (GAA repeats) are caused by trinucleotide repeats.
|AnswerE=Translocation t(2;13)
|AnswerE=Translocation t(2;13)
|AnswerEExp=Translocation t(2;13) is associated with [[rhabdomyosarcoma]].  This translocation fuses the ''FOXO1'' gene from chromosome 13 and the ''PAX3'' gene from chromosome 2.
|AnswerEExp=Translocation t(2;13) is associated with [[rhabdomyosarcoma]].  This translocation fuses the ''FOXO1'' gene from chromosome 13 and the ''PAX3'' gene from chromosome 2.
|EducationalObjectives=[[Nephroblastoma]] ([[Wilms tumor]]) is associated with the deletion of ''WT1'' gene on chromosome 11
|EducationalObjectives=[[Nephroblastoma]] ([[Wilms tumor]]) is associated with ''WT1'' gene deletion on chromosome 11
|References=Lee SB, Haber DA. Wilms tumor and the WT1 gene. Exp Cell Res. 2001;264(1):74-99.<br>
|References=Lee SB, Haber DA. Wilms tumor and the WT1 gene. Exp Cell Res. 2001;264(1):74-99.<br>
Nakamura L, Ritchey M. Current management of wilms' tumor. Curr Urol Rep. 2010;11(1):58-65.<br>
Nakamura L, Ritchey M. Current management of wilms' tumor. Curr Urol Rep. 2010;11(1):58-65.<br>

Revision as of 03:28, 10 November 2014

 
Author [[PageAuthor::Ogheneochuko Ajari, MB.BS, MS [1] (Reviewed by Will Gibson, Yazan Daaboul, M.D., Alison Leibowitz [2])]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Genetics
Sub Category SubCategory::Oncology, SubCategory::Renal
Prompt [[Prompt::A 3-year-old boy is brought to the pediatrician's office by his mother for bloody urine and abdominal pain. His temperature is 37.2 °C (98.96 °F), blood pressure is 144/90 mmHg, and heart rate is 70/min. Physical examination is remarkable for a large abdominal mass. Abdominal ultrasonography confirms the presence of a renal mass. CT scan demonstrates a solid renal mass with normal renal parenchyma towards its rim (claw sign). Which one of the following genetic alterations is responsible for this patient's condition?]]
Answer A AnswerA::Deletion on chromosome 11
Answer A Explanation [[AnswerAExp::Nephroblastoma (Wilms or Wilms' tumor) is often caused by WT1 tumor suppressor gene deletion on chromosome 11. WT1 is eponymously named Wilms Tumor 1 gene.]]
Answer B AnswerB::Mutation of ''TSC2''
Answer B Explanation [[AnswerBExp::TSC2 is a tumor suppressor gene in the MTOR pathway. Mutations in TSC2 cause tuberous sclerosis, which is characterized by the growth of benign tumors in the brain, skin, kidneys, and other organs.]]
Answer C AnswerC::Mutation of ''VHL''
Answer C Explanation [[AnswerCExp::The Von-Hippau-Lindau (VHL) gene encodes a ubiquitin-ligase responsible for increasing the degradation of Hypoxia-Inducible Factor (HIF), a transcription factor involved in a variety of gene products, such as Vascular Endothelial Growth Factor (VEGF). When the VHL gene is inactivated, HIF activity increases uncontrollably and initiates tumor formation in kidney cells. Germline mutations in the VHL tumor suppressor gene are associated with Von-Hippau-Lindau, a cancer-predisposing syndrome.]]
Answer D AnswerD::Trinucleotide repeats
Answer D Explanation AnswerDExp::Trinucleotide repeats is not associated with nephroblastoma. Huntington's disease (CAG repeats), myotonic dystrophy (CTG repeats), Fragile X syndrome (GAA repeats), and Friedreich ataxia (GAA repeats) are caused by trinucleotide repeats.
Answer E AnswerE::Translocation t(2;13)
Answer E Explanation [[AnswerEExp::Translocation t(2;13) is associated with rhabdomyosarcoma. This translocation fuses the FOXO1 gene from chromosome 13 and the PAX3 gene from chromosome 2.]]
Right Answer RightAnswer::A
Explanation [[Explanation::Nephroblastoma (Wilms tumor) is the most common pediatric kidney cancer. It arises from the pluripotent embryonic renal progenitor cells. Nephroblastoma usually manifests as a palpable abdominal mass that does not cross the midline. In addition, hematuria and high blood pressure may be present in 25% of the cases and suggest invasion of the renal pelvis and compression of the renal arteries, respectively. In advanced cases, metastasis may be present in the abdominal lymph nodes and the lungs. Unlike neuroblastoma, nephroblastoma rarely metastasizes to the bone, and patients rarely have symptoms of bone invasion (bone pain, fractures, or cytopenias).

Nephroblastoma may be present in isolation or may be caused by genetic deletions that involve the WT1 tumor suppressor gene in chromosome 11 that result in WAGR syndrome (Wilms tumor, aniridia, genitourinary abnormalities, and retardation). WT1 gene encodes a transcription factor that normally functions in the differentiation of renal and genitourinary tissue. Nephroblastoma has also been associated with Beckwith-Weidemann syndrome (hemihypertrophy of organs).

Generally, children with a palpable abdominal mass should first undergo an abdominal ultrasound; suspicious findings warrant an abdominal CT scan. The classical finding of nephroblastoma on abdominal CT scan include a solid renal mass with normal renal parenchyma towards its rim (claw sign), as observed in this patient. In contrast to neuroblastoma, calcifications are rare in nephroblastoma. Nephroblastoma is generally managed surgically followed by chemotherapy. Radiotherapy is reserved for advanced cases with metastasis. Upon resection, microscopic analysis of the tumor typically reveals immature blasts with primitive glomeruli, fibrous cells, and tubules.
Educational Objective: Nephroblastoma (Wilms tumor) is associated with WT1 gene deletion on chromosome 11
References: Lee SB, Haber DA. Wilms tumor and the WT1 gene. Exp Cell Res. 2001;264(1):74-99.
Nakamura L, Ritchey M. Current management of wilms' tumor. Curr Urol Rep. 2010;11(1):58-65.
Friedman AD. Wilms tumor. Pediatr Rev. 2013;34(7):328-30; discussion 330.
First Aid 2014 page 541]]

Approved Approved::Yes
Keyword WBRKeyword::Cancer, WBRKeyword::Tumor, WBRKeyword::Wilm's tumor, WBRKeyword::Wilms tumor, WBRKeyword::Kidney cancer, WBRKeyword::Beckwith-Weidemann syndrome, WBRKeyword::Childhood cancer, WBRKeyword::Pediatric cancer, WBRKeyword::Nephroblastoma, WBRKeyword::WT1, WBRKeyword::Tumor suppressor gene, WBRKeyword::WAGR syndrome, WBRKeyword::WAGR complex
Linked Question Linked::
Order in Linked Questions LinkedOrder::